0001375151-19-000024.txt : 20190308 0001375151-19-000024.hdr.sgml : 20190308 20190308164823 ACCESSION NUMBER: 0001375151-19-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190306 FILED AS OF DATE: 20190308 DATE AS OF CHANGE: 20190308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TANNENBAUM RENEE P CENTRAL INDEX KEY: 0001543174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19669752 MAIL ADDRESS: STREET 1: 9220 KIRBY DRIVE STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_155208168912225.xml FORM 4 X0306 4 2019-03-06 0 0001375151 ZOGENIX, INC. ZGNX 0001543174 TANNENBAUM RENEE P C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2019-03-06 4 M 0 9375 10.40 A 19375 D Common Stock 2019-03-06 4 M 0 6000 12.80 A 25375 D Common Stock 2019-03-06 4 M 0 20000 12.75 A 45375 D Common Stock 2019-03-06 4 M 0 20000 8.99 A 65375 D Common Stock 2019-03-06 4 S 0 17503 50.647 D 47872 D Stock Option (Right to Buy) 10.4 2019-03-06 4 M 0 9375 0 D 2025-02-05 Common Stock 9375.0 0 D Stock Option (Right to Buy) 12.8 2019-03-06 4 M 0 6000 0 D 2025-06-17 Common Stock 6000.0 3000 D Stock Option (Right to Buy) 8.99 2019-03-06 4 M 0 20000 0 D 2026-07-12 Common Stock 20000.0 0 D Stock Option (Right to Buy) 12.75 2019-03-06 4 M 0 20000 0 D 2027-05-22 Common Stock 20000.0 0 D The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $50.40 to $50.90, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option was granted on February 6, 2015, which is the vesting commencement date. Shares subject to the option vests over three years in thirty-six equal monthly installments, subject to the Reporting Person's continued service to the Company on each vesting date. The option was granted on June 18, 2015 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. The option was granted on July 13, 2016 and vests in a series of twelve (12) successive, equal monthly installments, on the first day of each calendar month following the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. The option was granted on May 23, 2017, the date of the Company's Annual Meeting of Stockholders, and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Renee P. Tannenbaum 2019-03-08